Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

710 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Modified cisplatin/interferon α-2b/doxorubicin/5-fluorouracil (PIAF) chemotherapy in patients with no hepatitis or cirrhosis is associated with improved response rate, resectability, and survival of initially unresectable hepatocellular carcinoma.
Kaseb AO, Shindoh J, Patt YZ, Roses RE, Zimmitti G, Lozano RD, Hassan MM, Hassabo HM, Curley SA, Aloia TA, Abbruzzese JL, Vauthey JN. Kaseb AO, et al. Among authors: vauthey jn. Cancer. 2013 Sep 15;119(18):3334-42. doi: 10.1002/cncr.28209. Epub 2013 Jul 2. Cancer. 2013. PMID: 23821538 Free PMC article.
Prospective trial of preoperative concomitant boost radiotherapy with continuous infusion 5-fluorouracil for locally advanced rectal cancer.
Janjan NA, Crane CN, Feig BW, Cleary K, Dubrow R, Curley SA, Ellis LM, Vauthey J, Lenzi R, Lynch P, Wolff R, Brown T, Pazdur R, Abbruzzese J, Hoff PM, Allen P, Brown B, Skibber J. Janjan NA, et al. Int J Radiat Oncol Biol Phys. 2000 Jun 1;47(3):713-8. doi: 10.1016/s0360-3016(00)00418-1. Int J Radiat Oncol Biol Phys. 2000. PMID: 10837955
Improved overall survival among responders to preoperative chemoradiation for locally advanced rectal cancer.
Janjan NA, Crane C, Feig BW, Cleary K, Dubrow R, Curley S, Vauthey JN, Lynch P, Ellis LM, Wolff R, Lenzi R, Abbruzzese J, Pazdur R, Hoff PM, Allen P, Brown T, Skibber J. Janjan NA, et al. Among authors: vauthey jn. Am J Clin Oncol. 2001 Apr;24(2):107-12. doi: 10.1097/00000421-200104000-00001. Am J Clin Oncol. 2001. PMID: 11319280 Clinical Trial.
Underlying liver disease, not tumor factors, predicts long-term survival after resection of hepatocellular carcinoma.
Bilimoria MM, Lauwers GY, Doherty DA, Nagorney DM, Belghiti J, Do KA, Regimbeau JM, Ellis LM, Curley SA, Ikai I, Yamaoka Y, Vauthey JN; International Cooperative Study Group on Hepatocellular Carcinoma. Bilimoria MM, et al. Among authors: vauthey jn. Arch Surg. 2001 May;136(5):528-35. doi: 10.1001/archsurg.136.5.528. Arch Surg. 2001. PMID: 11343543
710 results